JP2013515019A5 - - Google Patents

Download PDF

Info

Publication number
JP2013515019A5
JP2013515019A5 JP2012545091A JP2012545091A JP2013515019A5 JP 2013515019 A5 JP2013515019 A5 JP 2013515019A5 JP 2012545091 A JP2012545091 A JP 2012545091A JP 2012545091 A JP2012545091 A JP 2012545091A JP 2013515019 A5 JP2013515019 A5 JP 2013515019A5
Authority
JP
Japan
Prior art keywords
poloxamer
polysorbate
suspension
surfactant
particle size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012545091A
Other languages
English (en)
Japanese (ja)
Other versions
JP5816194B2 (ja
JP2013515019A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2010/000183 external-priority patent/WO2011076208A2/en
Publication of JP2013515019A publication Critical patent/JP2013515019A/ja
Publication of JP2013515019A5 publication Critical patent/JP2013515019A5/ja
Application granted granted Critical
Publication of JP5816194B2 publication Critical patent/JP5816194B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012545091A 2009-12-22 2010-12-22 カルシポトリオール一水和物ナノクリスタル Active JP5816194B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DK2009000267 2009-12-22
DKPCT/DK2009/000267 2009-12-22
US29309110P 2010-01-07 2010-01-07
US61/293,091 2010-01-07
PCT/DK2010/000183 WO2011076208A2 (en) 2009-12-22 2010-12-22 Calcipotriol monohydrate nanocrystals

Publications (3)

Publication Number Publication Date
JP2013515019A JP2013515019A (ja) 2013-05-02
JP2013515019A5 true JP2013515019A5 (https=) 2013-12-26
JP5816194B2 JP5816194B2 (ja) 2015-11-18

Family

ID=43618145

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012545091A Active JP5816194B2 (ja) 2009-12-22 2010-12-22 カルシポトリオール一水和物ナノクリスタル

Country Status (15)

Country Link
US (2) US20130039952A1 (https=)
EP (1) EP2515874B1 (https=)
JP (1) JP5816194B2 (https=)
CN (1) CN102770125B (https=)
AU (1) AU2010335655B2 (https=)
BR (1) BR112012015449B1 (https=)
CA (1) CA2785253A1 (https=)
ES (1) ES2523119T3 (https=)
IL (1) IL220516A (https=)
MX (1) MX2012007234A (https=)
NZ (1) NZ601000A (https=)
PL (1) PL2515874T3 (https=)
RU (1) RU2555339C2 (https=)
WO (1) WO2011076208A2 (https=)
ZA (1) ZA201204618B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX375448B (es) * 2013-07-18 2025-03-06 Mannkind Corp Composiciones farmacéuticas en polvo seco estables al calor y métodos.
CN105534996B (zh) * 2016-02-24 2018-05-01 长沙佰顺生物科技有限公司 一种治疗银屑病的药物组合物
BR112019000112A2 (pt) 2016-07-05 2019-04-09 Kratos LLC partículas do grupo iva micrônicas e sub-micrônicas pré-litiadas passivadas e métodos de preparação das mesmas
WO2018183909A1 (en) * 2017-03-31 2018-10-04 Kratos LLC Precharged negative electrode material for secondary battery
CN108904445A (zh) * 2018-08-06 2018-11-30 江苏知原药业有限公司 钙泊三醇纳米悬浮液
CN109157661B (zh) * 2018-09-10 2021-09-24 南京工业大学 一种配体辅助下用氧化物silica包覆疏水性分子晶体的方法
RU2749360C1 (ru) * 2020-10-09 2021-06-09 Федеральное государственное бюджетное военное образовательное учреждение высшего образования "Военно-медицинская академия имени С.М. Кирова" Министерства обороны Российской Федерации (ВМедА) Способ лечения ладонно-подошвенного пустулеза
JP7751298B2 (ja) * 2021-07-14 2025-10-08 株式会社ツツミプランニング 浸透深さの調整方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8315787D0 (en) * 1983-06-08 1983-07-13 Briggs J H Coolant spray
US4758432A (en) * 1984-10-15 1988-07-19 Richardson-Vicks Inc. Topical treatment of skin inflammatory disorders
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
GB9300763D0 (en) * 1993-01-15 1993-03-03 Leo Pharm Prod Ltd Chemical compound
DE4440337A1 (de) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
GB9504265D0 (en) * 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
DE19932157A1 (de) 1999-07-13 2001-01-18 Pharmasol Gmbh Verfahren zur schonenden Herstellung von hochfeinen Mikropartikeln und Nanopartikeln
US6403654B1 (en) * 2000-04-13 2002-06-11 Mariana De Oliveira Compositions for and method of treatment for psoriasis
KR100844285B1 (ko) * 2000-10-27 2008-07-09 레오 파마 에이/에스 하나 이상의 비타민 ｄ 또는 비타민 ｄ 동족체 및 하나이상의 코르티코스테로이드를 함유하는 국부용 조성물
AU2002239504A1 (en) * 2000-12-06 2002-06-18 Pharmacia Corporation Laboratory scale milling process
FR2834212B1 (fr) * 2001-12-27 2004-07-09 Besins Int Belgique Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques
JP2006511525A (ja) 2002-12-13 2006-04-06 ヤゴテック アーゲー ナノ粒子状スピロノラクトン局所製剤
DE602004027504D1 (de) 2003-07-24 2010-07-15 Leo Pharma As Aminobenzophenonverbindungen
AU2005240189A1 (en) * 2004-05-06 2005-11-17 Ivrea Pharmaceuticals, Inc. Particles for the delivery of active agents
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
ES2341473T3 (es) 2004-12-13 2010-06-21 Leo Pharma A/S Compuestos de aminobenzofenona sustituida con triazol.
EP2526930B1 (en) * 2005-06-01 2013-12-25 GlaxoSmithKline Intellectual Property Development Limited Vitamin formulation
US20070154402A1 (en) * 2005-10-24 2007-07-05 Collegium Pharmaceutical, Inc. Topical Pharmaceutical Foam Composition
AU2007264418B2 (en) * 2006-06-30 2012-05-03 Iceutica Pty Ltd Methods for the preparation of biologically active compounds in nanoparticulate form
EP2099420B8 (en) * 2006-11-17 2017-03-15 PharmaSol GmbH Nanocrystals for use in topical cosmetic formulations and method of production thereof
DE602007013617D1 (de) 2006-12-22 2011-05-12 Leo Pharma As Als pde4-inhibitoren geeignete substituierte acetophenone
RS53407B (sr) 2007-02-28 2014-10-31 Leo Pharma A/S Novi inhibitori fosfodiesteraze
US20100099710A1 (en) 2007-04-19 2010-04-22 Lene Jensen Src family kinase inhibitors
WO2008141078A1 (en) 2007-05-11 2008-11-20 Sonneborn Inc. Petrolatums having silicone-like properties
HRP20160488T1 (hr) 2008-12-19 2016-06-17 Leo Pharma A/S Triazolopiridini kao inhibitori fosfodiesteraze za liječenje kožnih bolesti

Similar Documents

Publication Publication Date Title
JP2013515019A5 (https=)
CN109963555A (zh) 一种包含美洛昔康的可注射的药物组合物及其制备方法
WO2012177886A3 (en) Process of forming crystals for use in a personal care composition
EP3495446A3 (en) Particles containing one or more controlled release cross-linked active agents
Jakubowska et al. Freeze-drying of drug nanosuspension–study of formulation and processing factors for the optimization and characterization of redispersible cilostazol nanocrystals
MX2023004255A (es) Comprimidos que comprenden 2-hidroxi-6-((2-(1-isopropil-1h-pirazol -5-il)piridin-3-il)metoxi)benzaldehido.
WO2012051426A3 (en) Aggregate nanoparticulate medicament formulations, manufacture and use thereof
NZ742004A (en) Pharmaceutical nanoparticles showing improved mucosal transport
WO2007107571A3 (en) Casting process
AR067747A1 (es) Metodos para producir suspension de aripiprazol y formulacion liofilizada
WO2011063990A3 (en) Spider silk particles for controlled and sustained delivery of compounds
WO2011106075A3 (en) A microelectronic structure including a low k dielectric and a method of controlling carbon distribution in the structure
MX2018011190A (es) Cuerpo de dispersion de particulas finas de material de proteccion de infrarrojo cercano, cuerpo de proteccion de infrarrojo cercano y estructura laminada de proteccion de infrarrojo cercano y metodo de produccion de los mismos.
WO2013132457A3 (en) Nanocrystalline solid dispersion compositions and process of preparation thereof
WO2010015298A3 (de) Kristalline wirkstoff-mikropartikel, verfahren zu deren herstellung und verwendung in arzneimitteln
WO2017177004A8 (en) Tertiary amides and method of use
NZ601000A (en) Calcipotriol monohydrate nanocrystals
CN107106524A (zh) 用于治疗原生动物感染的方法
Yu et al. Porous Al2O3 microspheres prepared by a novel ice-templated spray drying technique
WO2010102923A3 (en) Riluzole aqueous suspensions
CN102488920A (zh) 核壳结构的α-半水硫酸钙/羟基磷灰石复合颗粒及制备
Ogino et al. Preheating temperature and growth temperature dependence of InP nanowires grown by self-catalytic VLS mode on InP substrate
HK1214951A1 (zh) 眼用製劑
Kiew et al. Preserving the supersaturation generation capability of amorphous drug-polysaccharide nanoparticle complex after freeze drying
MX359554B (es) Microesferas cristalinas y proceso para fabricacion de las mismas.